Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
about
Direct thrombin inhibitors: pharmacology and clinical relevance.Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Successful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition.Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplantRecombinant activated factor VII and the anaesthetist.A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.Antithrombotic therapy for the CardioWest temporary total artificial heart.Controversies of anticoagulation reversal in life-threatening bleeds.Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.Medical emergencies: atrial fibrillation and myocardial infarction.Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies.
P2860
Q33366516-2B74D0AA-6301-4447-B958-9C6E2C4118D4Q33370224-21AF52DB-312F-4F1C-BB36-13853AA19CD0Q33370641-43458ECD-6B27-4374-B4F8-C417EACA8B01Q33373700-D2AB084B-33CD-4335-89CB-F8CBC673FF4CQ33374658-D6191447-9D72-4D94-B07B-4D132F3E9722Q33381805-CA7AAFEE-9A03-4805-8706-C2FBA224A436Q33393161-79FC3365-0477-4717-9EA5-27DCE55160DEQ33397666-4288B5B7-F02F-45F7-BC57-DE5B1AD56D02Q33431891-25EE544A-56B8-4B56-8A96-B00C58EB8C41Q35924900-4992963D-4C57-4F5E-A3F4-D0A64372A337Q36313315-0F215228-277B-4F33-B483-4F06DC2A01ECQ37095548-3C911022-0C2B-4453-B0C2-8C0C3A0C016DQ37710241-2911E6B7-822A-40FF-BE21-74C1916D153FQ37733290-0506BD88-68D2-4414-BA95-5D0751307A8CQ37867279-3E0BCCE4-F502-44DC-8A07-494EB8743B81Q37924500-2AC1C111-1EAB-48ED-A957-7F9A6A509055Q37978627-F1D0497A-6315-4E68-B044-4B80739F51A1Q38064908-7EE486CF-21B4-4177-B3B8-0832A6BBDA06Q52933033-18D907A0-77E9-429E-BD19-82949757DE03
P2860
Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@ast
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@en
type
label
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@ast
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@en
prefLabel
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@ast
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@en
P2093
P1476
Reversal of direct thrombin in ...... arin-induced thrombocytopenia.
@en
P2093
Anil M deSilva
Anthony J Romo
Charles W Hoopes
Elaine E Tseng
Greg Stratmann
Julie Hambleton
Michael J Mann
Michel Balea
Nancy L Achorn
William F Moskalik
P304
1635-9, table of contents
P356
10.1213/01.ANE.0000114072.71353.D5
P407
P577
2004-06-01T00:00:00Z